NCT00145795View on ClinicalTrials.gov

A Research Study to See if a Change in Therapy for HIV Infection Can Improve the Immune Response to Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

June 30, 2009

Study Completion Date

December 31, 2009

Conditions
HIV Infections
Interventions
DRUG

Kaletra + Current Dual NRTI Backbone

DRUG

Current Regimen

Trial Locations (1)

60607

University of Illinois at Chicago, Chicago

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

University of Chicago

OTHER